Cargando…

Orodispersible budesonide tablets for the treatment of eosinophilic esophagitis: a review of the latest evidence

Eosinophilic esophagitis (EoE) is a chronic inflammatory disorder of the esophagus characterized by symptoms of esophageal dysfunction and eosinophil-predominant inflammation. The incidence of EoE has increased substantially over the past two decades in Europe and North America. The natural course o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miehlke, Stephan, Lucendo, Alfredo J., Straumann, Alex, Jan Bredenoord, Albert, Attwood, Stephen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7288799/ https://www.ncbi.nlm.nih.gov/pubmed/32565912 http://dx.doi.org/10.1177/1756284820927282

Ejemplares similares

Budesonide orodispersible tablets for induction of remission in patients with active eosinophilic oesophagitis: A 6‐week open‐label trial of the EOS‐2 Programme
por: Miehlke, Stephan, et al.
Publicado: (2022)

Delayed hypersensitivity reaction to orodispersible budesonide in a case with eosinophilic esophagitis
por: Andrist, Caroline Michèle, et al.
Publicado: (2020)

Induction of Eosinophilic Esophagitis by Sublingual Pollen Immunotherapy
por: Miehlke, Stephan, et al.
Publicado: (2013)

Oral Hairy Leukoplakia Related to Orodispersible Budesonide Use
por: McNeice, Andrew, et al.
Publicado: (2020)

Evidence-based treatments for eosinophilic esophagitis: insights for the clinician
por: Feo-Ortega, Sara, et al.
Publicado: (2022)

Mucoadhesive Budesonide Formulation for the Treatment of Eosinophilic Esophagitis
por: Casiraghi, Antonella, et al.
Publicado: (2020)

Formulation and characterization of orodispersible tablet of glimepiride
por: Kinani, Ahmad AB Yosef, et al.
Publicado: (2022)

Erratum: Formulation and characterization of orodispersible tablet of glimepiride
Publicado: (2023)

A randomised, double-blind trial comparing budesonide formulations and dosages for short-term treatment of eosinophilic oesophagitis
por: Miehlke, Stephan, et al.
Publicado: (2016)

Pharmacokinetics of Budesonide Oral Suspension in Children and Adolescents With Eosinophilic Esophagitis
por: Gupta, Sandeep K., et al.
Publicado: (2022)

Orodispersible tablets: A new trend in drug delivery
por: Dey, Paramita, et al.
Publicado: (2010)

Pharmacotechnical and analytical preformulation studies for cannabidiol orodispersible tablets
por: Vlad, Robert-Alexandru, et al.
Publicado: (2021)

Eosinophilic cholangitis treatment with budesonide
por: De Roza, Marianne Anastasia, et al.
Publicado: (2017)

Taste Masked Microspheres of Ofloxacin: Formulation and Evaluation of Orodispersible Tablets
por: Malik, Karan, et al.
Publicado: (2011)

A survey of patient preferences for a placebo orodispersible tablet
por: Wade, Alan G, et al.
Publicado: (2012)

Preparation and Evaluation of Orodispersible Tablets of Pheniramine Maleate by Effervescent Method
por: Swamy, P. V., et al.
Publicado: (2009)

Development of Orodispersible Tablets of Candesartan Cilexetil-β-cyclodextrin Complex
por: Sravya, Maddukuri, et al.
Publicado: (2013)

Fused Deposition Modeling as a Possible Approach for the Preparation of Orodispersible Tablets
por: Tranová, Thao, et al.
Publicado: (2022)

A meta-analysis on randomized controlled trials of treating eosinophilic esophagitis with budesonide
por: Liu, Xiaopei, et al.
Publicado: (2022)

Esophageal Granular Cell Tumor and Eosinophilic Esophagitis: Two Interesting Entities Identified in the Same Patient
por: Lucendo, Alfredo J., et al.
Publicado: (2008)

Lallemantia reylenne seeds as superdisintegrant: Formulation and evaluation of nimesulide orodispersible tablets
por: Malik, Karan, et al.
Publicado: (2011)

Fast disintegrating crystalline solid dispersions of simvastatin for incorporation into orodispersible tablets
por: Pabari, Ritesh M, et al.
Publicado: (2014)

Development and optimization of carvedilol orodispersible tablets: enhancement of pharmacokinetic parameters in rabbits
por: Aljimaee, Yazeed HM, et al.
Publicado: (2015)

Formulation Design and Optimization of Orodispersible Tablets of Quetiapine Fumarate by Sublimation Method
por: Kalyankar, P., et al.
Publicado: (2015)

Pharmacokinetic Profiles of Ticagrelor Orodispersible Tablets in Healthy Western and Japanese Subjects
por: Teng, Renli, et al.
Publicado: (2017)

The Influence of the Intergranular Superdisintegrant Performance on New Drotaverine Orodispersible Tablet Formulations
por: Vlad, Robert-Alexandru, et al.
Publicado: (2023)

Mental distress among adult patients with eosinophilic esophagitis
por: de Rooij, Willemijn E., et al.
Publicado: (2020)

Adrenal suppression in children treated with swallowed fluticasone and oral viscous budesonide for eosinophilic esophagitis
por: Ahmet, Alexandra, et al.
Publicado: (2016)

Current concepts in eosinophilic esophagitis
por: Simon, Dagmar, et al.
Publicado: (2017)

Eosinophilic Esophagitis: Current Aspects of a Recently Recognized Disease
por: Lucendo, Alfredo J., et al.
Publicado: (2010)

Bioequivalence and Bioavailability of an Orodispersible Tablet of Sildenafil Citrate in Healthy Chinese Male Subjects
por: Lv, Yuan, et al.
Publicado: (2020)

Contribution to determining the antioxidant capacity of melatonin in orodispersible tablets – comparison with reference antioxidants
por: Muñoz, Herminia, et al.
Publicado: (2020)

Sugar content and erosive potential of commonly prescribed Orodispersible tablets- An in vitro study.
por: Anand, Lahari, et al.
Publicado: (2023)

Patients' preference for olanzapine orodispersible tablet compared with conventional oral tablet in a multinational, randomized, crossover study
por: Bitter, Istvan, et al.
Publicado: (2010)

Psychometric validation of the Dysphagia Symptom Questionnaire in patients with eosinophilic esophagitis treated with budesonide oral suspension
por: Hudgens, Stacie, et al.
Publicado: (2017)

General Well-being and Coping Strategies in Adult Eosinophilic Esophagitis Patients
por: de Rooij, Willemijn E, et al.
Publicado: (2022)

Eosinophilic esophagitis—established facts and new horizons
por: Biedermann, Luc, et al.
Publicado: (2021)

Eosinophilic esophagitis (EoE); a disease that must not be neglected - implications of esophageal rupture and its management
por: Larsson, Helen, et al.
Publicado: (2020)

Development of Orodispersible Tizanidine HCl Tablets Using Spray Dried Coprocessed Exipient Bases
por: Masareddy, Rajashree, et al.
Publicado: (2011)

Effect of a Disintegration Mechanism on Wetting, Water Absorption, and Disintegration Time of Orodispersible Tablets
por: Pabari, RM, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_lp0finlrt3p7ojk2hfcdi71qd2